What Factors Should Be Considered When Using Medicinal Gelatin Hollow Capsules?

As a common pharmaceutical excipient, medicinal gelatin hollow capsules need to balance safety, functionality, stability, and compliance comprehensively. The core concerns are as follows:

1, Safety: Strictly control the risks of raw materials and pollutants

Raw material compliance: Clearly identify the source of bone/skin gelatin, ensure that the raw materials come from compliant slaughterhouses, and provide proof of no mad cow disease for bovine gelatin to avoid epidemic areas or illegal channels.

Pollutant control: Heavy metals (lead, arsenic, etc.) ≤ 10ppm, total microbial count ≤ 1000CFU/g, sulfur dioxide residue ≤ 50ppm (Chinese Pharmacopoeia), preservatives (such as parabens) residue meets Pharmacopoeia standards, crosslinking agent residue ≤ 0.1ppm.

Allergen labeling: Gelatin is an animal derived protein and should be labeled with potential allergy risks to avoid cross contamination with other animal proteins.

2, Functional: Match drug characteristics and usage requirements

Drug adaptation: For immediate release drugs, choose ordinary capsules (dissolution ≤ 30 minutes), and for sustained-release/enteric coated drugs, choose specialized capsules (acid resistant, small intestine release); Moisture absorbing drugs require low moisture permeable capsules, while alkaline drugs require compatibility verification.

Mechanical properties: The brittleness of hard capsules is ≤ 10%, and soft capsules need to pass a -10 ℃ low-temperature test with a dimensional tolerance of ≤± 0.3mm to adapt to filling equipment.

Special scenarios: Light sensitive medication with light blocking capsules (added with titanium dioxide), children's medication with small size (such as size 5) or easy to swallow design.

3, Stability: Standardized storage and shelf life management

Environmental control: Storage temperature 15-25 ℃, relative humidity ≤ 60%, dark packaging (aluminum foil bag/brown bottle), avoid high temperature adhesion or low temperature brittleness.

Validity verification: Through accelerated testing at 40 ℃/75% RH (3 months) and long-term testing at 25 ℃/60% RH (≥ 24 months), the compatibility between the drug and the capsule (no adsorption, degradation) is simultaneously verified.

4, Compliance and Supply Chain: Balancing Compliance with Regulations and Costs

Regulatory compliance: Complies with the Chinese Pharmacopoeia/USP/EP standards, with specifications, batch numbers, and "medicinal" labeling. Enteric coated capsules must be clearly labeled; DMF files should be provided during the associated review, and any changes need to be revalidated.

Cost and supply chain: Bone gelatin has a lower cost than skin gelatin, and GMP certified suppliers are preferred. Establish at least 2 alternative suppliers; Transport temperature controlled vehicles to avoid environmental fluctuations affecting quality.